Drug Manufacturing, Data Falsification Scandal In Japan leads To Regulatory Tightening
This article was originally published in SRA
Executive Summary
Using unapproved ingredients, changing information on production records and artificially aging doctored records with ultraviolet light: these are just some of the irregularities that have allegedly taken place at Japan's major vaccines and blood products manufacturer Kaketsuken (Chemo-Sero Therapeutic Research Inst.) over a 40-year period.